| abstract |
The present invention provides a pharmaceutical composition comprising an effective amount of a ghrelin matrix or a pharmaceutically acceptable salt, hydrate or solvate thereof and a serotonin 5-HT 1B / 1D receptor agonist, a tryptamine derivative, an ergoline derivative, a non- steroidal anti- At least one migraine treatment agent selected from the group consisting of a combination of agents for treating migraine and a method for treating migraine. |